Find clinical trials for Multiple Myeloma in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Warszawa, Mazowieckie, POL:
low-dose dexamethasone (SVd) versus bortezomib plus low-dose dexamethasone (Vd) in adult patients with RRMM who have received 1 to 3 prior anti-multiple...
Phase 3
Warsaw, Poland and 156 other locations
monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Pa...
Phase 3
Warszawa, Poland and 210 other locations
(Arm A) versus daratumumab in combination with bortezomib/dexamethasone (Arm B) in the participants with relapsed recurrent multiple myeloma...
Phase 3
Warszawa, Poland and 150 other locations
with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple...
Phase 3
Warszawa, Poland and 256 other locations
compared with VMP alone in participants with previously untreated multiple myeloma who are ineligible for high dose chemotherapy an...
Phase 3
Warszawa, Poland and 164 other locations
This open-label, randomized study for evaluating the efficacy and safety of single agent belantamab mafodotin when compared to pom/dex in participant...
Phase 3
Warszawa, Poland and 140 other locations
This study aims to evaluate alternative dosing regimens of single-agent belantamab mafodotin in participants with relapsed or refractory multiple...
Phase 2
Warszawa, Poland and 101 other locations
Elranatamab is a bispecific antibody: binding of elranatamab to CD3-expressing T-cells and BCMA-expressing multiple myeloma cells c...
Phase 3
Warszawa, Mazowieckie, Poland and 71 other locations
PREDATOR is a study investigating a role of preemptive daratumumab therapy for preclinical relapse or progression of multiple myeloma...
Phase 2
Warszawa, Mazowieckie, Poland and 1 other location
antibody, daratumumab, can provide more benefit to people with multiple myeloma compared to a combination therapy including daratum ...
Phase 3
Warszawa, Poland and 273 other locations
Clinical trials
Research sites
Resources
Legal